DANIEL R. OMSTEAD, PHD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

abrdn Healthcare Investors

Filing Date Source Excerpt
2019-04-15 Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC... He serves on their Valuation Committee... For the fiscal year ended September 30, 2018... Daniel R. Omstead, PhD... $0.

abrdn Life Sciences Investors

Filing Date Source Excerpt
2019-04-15 Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC, President of the Fund, and serves on its Valuation Committee. ... For the fiscal year ended September 30, 2018, the Fund paid no compensation to Dr. Omstead as he is an interested trustee and receives indirect compensation from the investment advisory fee paid to the Adviser.

Data sourced from SEC filings. Last updated: 2026-02-03